Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0457 Transporter Info | ||||
| Gene Name | SLC6A5 | ||||
| Protein Name | Sodium- and chloride-dependent glycine transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs2298826 | ||||
| Site of GPD | chr11:20638211 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | A=0.3522/1764 (Global) | ||||
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Haloperidol | Drug Info | Schizophrenia | Correlated with the motor side effects in patients (compare with genotypes AG + GG) | [ 1] | |
| References | |||||
| 1 | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenet Genomics. 2011 Apr;21(4):206-16. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.